IP & Copyright
Lawmakers' Drug Pricing Myth: Patents Aren't the Villain Blocking Generics
Think Big Pharma's patent tricks keep generics off shelves forever? Wrong. Data proves otherwise, yet Washington bites the myth anyway. Who's really cashing in?